Secondary to the atrophy of the cerebellum, patients develop ataxia; PMM2-CDG is associated with the CACNA1A gene gain-of-function mutation that encodes the voltage-gated CaV2.1 channel [93,94]. Here, CACNA1A is linked to Ataxia.